Literature DB >> 30496800

High-grade squamous cell carcinoma arising in a tibial adamantinoma.

Nooshin K Dashti1, Benjamin Matthew Howe2, Carrie Y Inwards1, Karen J Fritchie1, Jodi M Carter3.   

Abstract

Adamantinoma of the long bones is a rare, typically low-grade malignant tumor that frequently involves the tibia. Radiographically, adamantinoma is characteristically a lytic, intracortical, and expansile lesion with variable margins. Histologically, adamantinoma is a bimorphic neoplasm, composed of epithelial and osteofibrous elements. Herein, we describe a 72-year-old man with a long-standing tibial mass that, on imaging, rapidly developed cortical destruction with soft tissue extension. Imaging revealed no evidence of a distant site of origin. Needle core biopsy demonstrated high-grade squamous cell carcinoma, and metastasis was initially favored. However, the combined clinicoradiologic and pathologic features were most compatible with a high-grade squamous cell carcinoma arising in adamantinoma. The diagnosis was confirmed in the resection specimen. Both the age at presentation and histologic features make this case unusual and highlight a potential for misdiagnosis in the evaluation of squamous cell carcinoma-containing lesions of the tibia, reinforcing the importance of clinicoradiologic correlation in bone pathology.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adamantinoma of the long bone; High-grade; Metastasis; Squamous cell carcinoma; Tibia

Mesh:

Year:  2018        PMID: 30496800     DOI: 10.1016/j.humpath.2018.11.018

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  2 in total

Review 1.  Adamantinoma: An Updated Review.

Authors:  Dimitrios N Varvarousis; Georgios P Skandalakis; Alexandra Barbouti; Georgios Papathanakos; Panagiotis Filis; Kostas Tepelenis; Aikaterini Kitsouli; Panagiotis Kanavaros; Panagiotis Kitsoulis
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

2.  Epidemiological Study of Adamantinoma from US Surveillance, Epidemiology, and End Results Program: III Retrospective Analysis.

Authors:  Mahmut Nedim Aytekin; Recep Öztürk; Kamil Amer
Journal:  J Oncol       Date:  2020-06-16       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.